BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15659806)

  • 1. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
    Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T
    Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G
    Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.
    Massa A; Barbieri F; Aiello C; Arena S; Pattarozzi A; Pirani P; Corsaro A; Iuliano R; Fusco A; Zona G; Spaziante R; Florio T; Schettini G
    J Biol Chem; 2004 Jul; 279(28):29004-12. PubMed ID: 15123617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
    Barbieri F; Pattarozzi A; Gatti M; Porcile C; Bajetto A; Ferrari A; Culler MD; Florio T
    Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
    Watt HL; Kharmate GD; Kumar U
    Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
    Florio T
    Mol Cell Endocrinol; 2008 May; 286(1-2):40-8. PubMed ID: 17913342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.
    Barbieri F; Pattarozzi A; Gatti M; Aiello C; Quintero A; Lunardi G; Bajetto A; Ferrari A; Culler MD; Florio T
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1078-88. PubMed ID: 19706788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
    Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
    Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
    Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2.
    Vilimanovich U; Bumbasirevic V
    Cell Mol Life Sci; 2008 Mar; 65(5):814-26. PubMed ID: 18239851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2.
    Posser T; de Aguiar CB; Garcez RC; Rossi FM; Oliveira CS; Trentin AG; Neto VM; Leal RB
    Arch Toxicol; 2007 Jun; 81(6):407-14. PubMed ID: 17333127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.
    Martín V; Herrera F; Carrera-Gonzalez P; García-Santos G; Antolín I; Rodriguez-Blanco J; Rodriguez C
    Cancer Res; 2006 Jan; 66(2):1081-8. PubMed ID: 16424044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2.
    Massa A; Casagrande S; Bajetto A; Porcile C; Barbieri F; Thellung S; Arena S; Pattarozzi A; Gatti M; Corsaro A; Robello M; Schettini G; Florio T
    Ann N Y Acad Sci; 2006 Dec; 1090():385-98. PubMed ID: 17384283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
    Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.
    Yoshino Y; Aoyagi M; Tamaki M; Duan L; Morimoto T; Ohno K
    Int J Oncol; 2006 Oct; 29(4):981-7. PubMed ID: 16964394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effects of tocopherols (vitamin E) on murine glioma C6 cells: homologue-specific control of PKC/ERK and cyclin signaling.
    Betti M; Minelli A; Canonico B; Castaldo P; Magi S; Aisa MC; Piroddi M; Di Tomaso V; Galli F
    Free Radic Biol Med; 2006 Aug; 41(3):464-72. PubMed ID: 16843827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.